CrushSCI.com
110.2平均天数
111中位天数
42最短天数
237最长天数
1762025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

111 天

Inhibition of pancreatic cancer growth by an siRNA targeting SNORA22 and a folic acid-conjugated cationic oligopeptide

作者
Kazuhiro Hiyama; Miki Nishigawa; Kazunori Takagi; Kazuki Sato; Rintaro Iwata Hara; Kaoru Furihata; Kazushige Uchida; Takeshi Wada; Keisuke Taniuchi展开收起
作者单位
1. https://ror.org/01xxp6985grid.278276.e0000 0001 0659 9825Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi University,Nankoku, Kochi 783-8505 Japan; 2. https://ror.org/05sj3n476grid.143643.70000 0001 0660 6861Faculty of Pharmaceutical Sciences, Tokyo University of Science,Katsushika-ku, Tokyo, 125-8585 Japan; 3. https://ror.org/05dqf9946NucleoTIDE and PepTIDE Drug Discovery Center, Institute of Integrated Research, Institute of Science Tokyo,Bunkyo-ku, Tokyo, 113-8519 Japan; 4. https://ror.org/01xxp6985grid.278276.e0000 0001 0659 9825Department of Pathology, Kochi Medical School, Kochi University,Nankoku, Kochi 783-8505 Japan展开收起
官方全文证据 DOI 网页
118 天

Cytotoxic and genotoxic effects of oxime β-lapachone in human cancer cells: selectivity toward NCI-H460 and insights from molecular docking

作者
Maria Francilene Souza Silva; Lara Polyana Silva Ramos; Fátima de Cássia Evangelista de Oliveira; Bruno Marques Soares; Daniel Pascoalino Pinheiro; Igor Frederico da Silveira Ramos; Rayran Walter Sousa; Victória Laysna dos Anjos Santos; Arlan de Assis Gonsalves; Paulo Michel Pinheiro Ferreira; Heurison Sousa e Silva; Cleônia Roberta de Melo Araújo; Claudia Pessoa; Marcia dos Santos Rizzo; Marcília Pinheiro Costa展开收起
作者单位
1. https://ror.org/03srtnf24grid.8395.70000 0001 2160 0329Laboratory of Experimental Oncology, Research and Development Center for Pharmaceuticals (NPDM), Federal University of Ceará,Fortaleza, CE 6430-275 Brazil; 2. https://ror.org/02ynbzc81grid.412275.70000 0004 4687 5259Health Sciences Center, Center for Experimental Biology (Nubex), University of Fortaleza (UNIFOR),Fortaleza, CE Brazil; 3. https://ror.org/00kwnx126grid.412380.c0000 0001 2176 3398Interdisciplinary Laboratory for Advanced Materials (LIMAV), Graduate Program in Pharmaceutical Sciences, Federal University of Piauí,Teresina, PI 64049-550 Brazil; 4. https://ror.org/00kwnx126grid.412380.c0000 0001 2176 3398Laboratory of Experimental Cancerology (LabCancer), Department of Biophysics and Physiology, Federal University of Piauí,Teresina, PI 64049-550 Brazil; 5. https://ror.org/00devjr72grid.412386.a0000 0004 0643 9364Graduate Program in Health and Biological Sciences, Federal University of the São Francisco Valley,Petrolina, PE 56304-917 Brazil; 6. https://ror.org/00kwnx126grid.412380.c0000 0001 2176 3398Department of Physics, Federal University of Piauí,Teresina, PI 64049-550 Brazil展开收起
官方全文证据 DOI 网页
237 天

CCL21/CCR7 axis regulates VEGF-D m6A modification to drive lymphangiogenesis and lymphatic metastasis in gallbladder cancer

作者
Zhenheng Wu; Xinran Cai; Lei Jiang; Bin Lin; Wei Pan; Shengzhe Lin; Yanling Chen; Haijie Hong展开收起
作者单位
1. https://ror.org/055gkcy74grid.411176.40000 0004 1758 0478Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union Hospital,29 Xinquan Road, Fuzhou, 350001 Fujian China; 2. https://ror.org/050s6ns64grid.256112.30000 0004 1797 9307Fujian Medical University Cancer Center,Fuzhou, 350122 Fujian China; 3. https://ror.org/050s6ns64grid.256112.30000 0004 1797 9307Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fujian Medical University,Fuzhou, 350122 Fujian China; 4. https://ror.org/030e09f60grid.412683.a0000 0004 1758 0400Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University,Fuzhou, 350004 Fujian China; 5. Fujian Center for Drug Evaluation and Monitoring, Fuzhou, 350001 Fujian China展开收起
官方全文证据 DOI 网页
43 天

Interaction of Listeria monocytogenes with the human choroid plexus endothelium in vitro: impact on invasion of the epithelium

作者
Carolin Stump-Guthier; Sandrin Schulze; Walter Muranyi; Mobarak Abu Mraheil; Torsten Hain; Michael Hagmann; Hiroshi Ishikawa; Horst Schroten; Christian Schwerk; Stefan Weichert展开收起
作者单位
1. https://ror.org/038t36y30grid.7700.00000 0001 2190 4373Pediatric Infectious Diseases, Department of Pediatrics, Medical Faculty Mannheim, Heidelberg University,68167 Mannheim, Germany; 2. https://ror.org/033eqas34grid.8664.c0000 0001 2165 8627Institute of Medical Microbiology, German Center for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Justus-Liebig University Giessen,35392 Giessen, Germany; 3. https://ror.org/038t36y30grid.7700.00000 0001 2190 4373Department of Medical Statistics, Biomathematics and Information Processing, Medical Faculty Mannheim, Heidelberg University,68167 Mannheim, Germany; 4. https://ror.org/02956yf07grid.20515.330000 0001 2369 4728Laboratory of Clinical Regenerative Medicine, Department of Neurosurgery, Faculty of Medicine, University of Tsukuba,1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575 Japan展开收起
官方全文证据 DOI 网页
42 天

Establishment and characterization of TRI-LC21: a novel patient-derived cell line of SMARCA4-deficient undifferentiated thoracic tumor

作者
Shasha Li; Hao Luo; Dongsheng Wu; Yin Ku; Nanzhi Luo; Zhipeng Gong; Wenjing Zhou; Xinyi Xie; Guanyu Zhou; Yaohui Chen; Lunxu Liu展开收起
作者单位
1. https://ror.org/007mrxy13grid.412901.f0000 0004 1770 1022Department of Thoracic Surgery and Institute of Thoracic Oncology , West China Hospital, Sichuan University,Chengdu, 610041 China展开收起
官方全文证据 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。